<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>DEALSCOPE ‚Äî Precedent Transactions</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&family=Fraunces:opsz,wght@9..144,400;9..144,600&family=JetBrains+Mono:wght@400;500&display=swap" rel="stylesheet">
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        :root {
            --white: #ffffff;
            --gray-50: #f8fafc;
            --gray-100: #f1f5f9;
            --gray-200: #e2e8f0;
            --gray-300: #cbd5e1;
            --gray-400: #94a3b8;
            --gray-500: #64748b;
            --gray-600: #475569;
            --gray-700: #334155;
            --gray-800: #1e293b;
            --gray-900: #0f172a;
            --teal: #0d9488;
            --teal-light: #14b8a6;
            --amber: #d97706;
            --red: #dc2626;
            --green: #16a34a;
            --blue: #2563eb;
        }

        body {
            font-family: 'Inter', sans-serif;
            background: var(--gray-50);
            color: var(--gray-800);
            min-height: 100vh;
        }

        /* Top Bar */
        .topbar {
            display: flex;
            align-items: center;
            justify-content: space-between;
            padding: 1rem 2rem;
            background: var(--white);
            border-bottom: 1px solid var(--gray-200);
        }

        .topbar-left {
            display: flex;
            align-items: center;
            gap: 1.5rem;
        }

        .back-link {
            color: var(--gray-500);
            text-decoration: none;
            font-size: 0.9rem;
        }

        .page-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--gray-900);
        }

        .btn {
            padding: 0.6rem 1.25rem;
            font-size: 0.85rem;
            font-weight: 500;
            border-radius: 8px;
            cursor: pointer;
            transition: all 0.2s;
            background: var(--white);
            border: 1px solid var(--gray-300);
            color: var(--gray-700);
        }

        /* Main Layout */
        .main-layout {
            display: grid;
            grid-template-columns: 320px 1fr;
            min-height: calc(100vh - 65px);
        }

        /* Left: Filters */
        .filter-panel {
            background: var(--white);
            border-right: 1px solid var(--gray-200);
            padding: 1.5rem;
        }

        .panel-title {
            font-size: 0.7rem;
            font-weight: 600;
            color: var(--gray-500);
            text-transform: uppercase;
            letter-spacing: 0.1em;
            margin-bottom: 1rem;
        }

        .current-deal {
            background: linear-gradient(135deg, rgba(13, 148, 136, 0.08) 0%, var(--white) 100%);
            border: 1px solid rgba(13, 148, 136, 0.2);
            border-radius: 12px;
            padding: 1rem;
            margin-bottom: 1.5rem;
        }

        .deal-name {
            font-weight: 600;
            font-size: 1rem;
            color: var(--gray-900);
            margin-bottom: 0.5rem;
        }

        .deal-tags {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
        }

        .deal-tag {
            font-size: 0.7rem;
            background: var(--white);
            border: 1px solid var(--gray-200);
            padding: 0.25rem 0.5rem;
            border-radius: 4px;
            color: var(--gray-600);
        }

        /* Filter Groups */
        .filter-group {
            margin-bottom: 1.5rem;
        }

        .filter-label {
            font-size: 0.85rem;
            font-weight: 500;
            color: var(--gray-700);
            margin-bottom: 0.75rem;
        }

        .filter-chips {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
        }

        .filter-chip {
            font-size: 0.75rem;
            padding: 0.4rem 0.75rem;
            background: var(--gray-100);
            border: 1px solid var(--gray-200);
            border-radius: 20px;
            cursor: pointer;
            transition: all 0.2s;
            color: var(--gray-600);
        }

        .filter-chip:hover {
            background: var(--gray-200);
        }

        .filter-chip.active {
            background: var(--teal);
            color: white;
            border-color: var(--teal);
        }

        /* Range Control */
        .range-control {
            margin-bottom: 1.5rem;
        }

        .range-header {
            display: flex;
            justify-content: space-between;
            margin-bottom: 0.5rem;
        }

        .range-value {
            font-family: 'JetBrains Mono', monospace;
            font-size: 0.85rem;
            color: var(--teal);
            font-weight: 500;
        }

        .range-track {
            height: 6px;
            background: var(--gray-200);
            border-radius: 3px;
            position: relative;
        }

        .range-fill {
            position: absolute;
            height: 100%;
            background: var(--teal);
            border-radius: 3px;
            left: 10%;
            width: 65%;
        }

        /* Main Content */
        .main-content {
            padding: 1.5rem 2rem;
        }

        .results-header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-bottom: 1.5rem;
        }

        .results-header h2 {
            font-family: 'Fraunces', serif;
            font-size: 1.5rem;
            font-weight: 600;
            color: var(--gray-900);
        }

        .results-count {
            font-size: 0.85rem;
            color: var(--gray-500);
        }

        .sort-select {
            display: flex;
            align-items: center;
            gap: 0.5rem;
            padding: 0.5rem 1rem;
            background: var(--white);
            border: 1px solid var(--gray-200);
            border-radius: 8px;
            font-size: 0.85rem;
            cursor: pointer;
            color: var(--gray-600);
        }

        /* Precedent Cards */
        .precedent-grid {
            display: flex;
            flex-direction: column;
            gap: 1rem;
        }

        .precedent-card {
            background: var(--white);
            border: 1px solid var(--gray-200);
            border-radius: 12px;
            padding: 1.5rem;
            display: grid;
            grid-template-columns: 1fr 200px 160px;
            gap: 2rem;
            align-items: center;
            transition: all 0.2s;
        }

        .precedent-card:hover {
            border-color: var(--teal);
            box-shadow: 0 4px 12px rgba(0,0,0,0.05);
        }

        .precedent-main {
            display: flex;
            gap: 1rem;
        }

        .similarity-badge {
            width: 56px;
            height: 56px;
            border-radius: 10px;
            display: flex;
            flex-direction: column;
            align-items: center;
            justify-content: center;
            flex-shrink: 0;
        }

        .similarity-badge.high {
            background: #dcfce7;
            color: var(--green);
        }

        .similarity-badge.medium {
            background: #fef3c7;
            color: var(--amber);
        }

        .similarity-score {
            font-family: 'JetBrains Mono', monospace;
            font-size: 1.1rem;
            font-weight: 700;
        }

        .similarity-label {
            font-size: 0.6rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .precedent-info h3 {
            font-size: 1rem;
            font-weight: 600;
            color: var(--gray-900);
            margin-bottom: 0.25rem;
        }

        .precedent-meta {
            font-size: 0.85rem;
            color: var(--gray-500);
            margin-bottom: 0.75rem;
        }

        .precedent-tags {
            display: flex;
            flex-wrap: wrap;
            gap: 0.4rem;
        }

        .tag {
            font-size: 0.7rem;
            padding: 0.2rem 0.5rem;
            background: var(--gray-100);
            border-radius: 4px;
            color: var(--gray-600);
        }

        .tag.match {
            background: rgba(13, 148, 136, 0.1);
            color: var(--teal);
        }

        /* Deal Metrics */
        .precedent-metrics {
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 0.75rem;
        }

        .metric {
            text-align: center;
        }

        .metric-value {
            font-family: 'JetBrains Mono', monospace;
            font-size: 1rem;
            font-weight: 600;
            color: var(--gray-900);
        }

        .metric-label {
            font-size: 0.7rem;
            color: var(--gray-500);
        }

        /* Outcome */
        .precedent-outcome {
            text-align: center;
        }

        .outcome-status {
            display: inline-flex;
            align-items: center;
            gap: 0.4rem;
            padding: 0.4rem 0.75rem;
            border-radius: 20px;
            font-size: 0.8rem;
            font-weight: 600;
            margin-bottom: 0.25rem;
        }

        .outcome-status.completed {
            background: #dcfce7;
            color: var(--green);
        }

        .outcome-status.terminated {
            background: #fee2e2;
            color: var(--red);
        }

        .outcome-detail {
            font-size: 0.75rem;
            color: var(--gray-500);
        }

        /* AI Insights */
        .insights-section {
            background: linear-gradient(135deg, rgba(13, 148, 136, 0.08) 0%, var(--white) 100%);
            border: 1px solid rgba(13, 148, 136, 0.2);
            border-radius: 16px;
            padding: 1.5rem;
            margin-top: 1.5rem;
        }

        .insights-header {
            display: flex;
            align-items: center;
            gap: 0.75rem;
            margin-bottom: 1.25rem;
        }

        .insights-icon {
            width: 40px;
            height: 40px;
            background: linear-gradient(135deg, var(--teal) 0%, var(--teal-light) 100%);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.1rem;
        }

        .insights-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--gray-900);
        }

        .insights-subtitle {
            font-size: 0.85rem;
            color: var(--gray-500);
        }

        .insights-grid {
            display: grid;
            grid-template-columns: repeat(3, 1fr);
            gap: 1.25rem;
        }

        .insight-card {
            background: var(--white);
            border-radius: 10px;
            padding: 1.25rem;
            border: 1px solid var(--gray-200);
        }

        .insight-stat {
            font-family: 'JetBrains Mono', monospace;
            font-size: 1.75rem;
            font-weight: 700;
            color: var(--teal);
            margin-bottom: 0.5rem;
        }

        .insight-label {
            font-size: 0.9rem;
            font-weight: 500;
            color: var(--gray-700);
            margin-bottom: 0.5rem;
        }

        .insight-detail {
            font-size: 0.8rem;
            color: var(--gray-500);
            line-height: 1.5;
        }
    </style>
</head>
<body>
    <div class="topbar">
        <div class="topbar-left">
            <a href="08-dashboard.html" class="back-link">‚Üê NovaPharma Deal</a>
            <h1 class="page-title">Precedent Transactions</h1>
        </div>
        <button class="btn">Export Comps</button>
    </div>

    <div class="main-layout">
        <!-- Filters -->
        <aside class="filter-panel">
            <div class="panel-title">Matching Against</div>
            
            <div class="current-deal">
                <div class="deal-name">NovaPharma Inc.</div>
                <div class="deal-tags">
                    <span class="deal-tag">Healthcare</span>
                    <span class="deal-tag">$890M</span>
                    <span class="deal-tag">Biotech</span>
                    <span class="deal-tag">Phase 3</span>
                </div>
            </div>

            <div class="filter-group">
                <div class="filter-label">Industry</div>
                <div class="filter-chips">
                    <span class="filter-chip active">All Pharma</span>
                    <span class="filter-chip active">Biotech</span>
                    <span class="filter-chip">Medical Devices</span>
                    <span class="filter-chip">Healthcare IT</span>
                </div>
            </div>

            <div class="filter-group">
                <div class="filter-label">Deal Type</div>
                <div class="filter-chips">
                    <span class="filter-chip active">Acquisition</span>
                    <span class="filter-chip">Merger</span>
                    <span class="filter-chip">Asset Sale</span>
                </div>
            </div>

            <div class="range-control">
                <div class="range-header">
                    <span class="filter-label">Deal Size</span>
                    <span class="range-value">$500M ‚Äì $2B</span>
                </div>
                <div class="range-track">
                    <div class="range-fill"></div>
                </div>
            </div>

            <div class="filter-group">
                <div class="filter-label">Time Period</div>
                <div class="filter-chips">
                    <span class="filter-chip">2024</span>
                    <span class="filter-chip active">2023</span>
                    <span class="filter-chip active">2022</span>
                    <span class="filter-chip active">2021</span>
                </div>
            </div>

            <div class="filter-group">
                <div class="filter-label">Special Conditions</div>
                <div class="filter-chips">
                    <span class="filter-chip active">Has CoC Clause</span>
                    <span class="filter-chip active">Pending FDA</span>
                    <span class="filter-chip">License-dependent</span>
                    <span class="filter-chip">Earnout</span>
                </div>
            </div>
        </aside>

        <!-- Results -->
        <main class="main-content">
            <div class="results-header">
                <div>
                    <h2>Similar Transactions</h2>
                    <span class="results-count">23 matches found based on your deal profile</span>
                </div>
                <div class="sort-select">Sort by: Similarity ‚ñº</div>
            </div>

            <div class="precedent-grid">
                <!-- Precedent 1 -->
                <div class="precedent-card">
                    <div class="precedent-main">
                        <div class="similarity-badge high">
                            <span class="similarity-score">94%</span>
                            <span class="similarity-label">Match</span>
                        </div>
                        <div class="precedent-info">
                            <h3>AbbVie / Allergan</h3>
                            <div class="precedent-meta">May 2020 ‚Ä¢ Strategic Acquisition</div>
                            <div class="precedent-tags">
                                <span class="tag match">Pharma</span>
                                <span class="tag match">CoC Clause</span>
                                <span class="tag match">License-dependent</span>
                            </div>
                        </div>
                    </div>
                    <div class="precedent-metrics">
                        <div class="metric">
                            <div class="metric-value">$63B</div>
                            <div class="metric-label">Deal Value</div>
                        </div>
                        <div class="metric">
                            <div class="metric-value">12.4x</div>
                            <div class="metric-label">EV/EBITDA</div>
                        </div>
                        <div class="metric">
                            <div class="metric-value">45%</div>
                            <div class="metric-label">Premium</div>
                        </div>
                        <div class="metric">
                            <div class="metric-value">8 mo</div>
                            <div class="metric-label">Time to Close</div>
                        </div>
                    </div>
                    <div class="precedent-outcome">
                        <span class="outcome-status completed">‚úì Completed</span>
                        <div class="outcome-detail">All consents obtained</div>
                    </div>
                </div>

                <!-- Precedent 2 -->
                <div class="precedent-card">
                    <div class="precedent-main">
                        <div class="similarity-badge high">
                            <span class="similarity-score">91%</span>
                            <span class="similarity-label">Match</span>
                        </div>
                        <div class="precedent-info">
                            <h3>Bristol-Myers / Celgene</h3>
                            <div class="precedent-meta">Nov 2019 ‚Ä¢ Strategic Acquisition</div>
                            <div class="precedent-tags">
                                <span class="tag match">Biotech</span>
                                <span class="tag match">Pending FDA</span>
                                <span class="tag match">CoC Clause</span>
                            </div>
                        </div>
                    </div>
                    <div class="precedent-metrics">
                        <div class="metric">
                            <div class="metric-value">$74B</div>
                            <div class="metric-label">Deal Value</div>
                        </div>
                        <div class="metric">
                            <div class="metric-value">14.2x</div>
                            <div class="metric-label">EV/EBITDA</div>
                        </div>
                        <div class="metric">
                            <div class="metric-value">54%</div>
                            <div class="metric-label">Premium</div>
                        </div>
                        <div class="metric">
                            <div class="metric-value">11 mo</div>
                            <div class="metric-label">Time to Close</div>
                        </div>
                    </div>
                    <div class="precedent-outcome">
                        <span class="outcome-status completed">‚úì Completed</span>
                        <div class="outcome-detail">CVR issued for FDA outcome</div>
                    </div>
                </div>

                <!-- Precedent 3 -->
                <div class="precedent-card">
                    <div class="precedent-main">
                        <div class="similarity-badge high">
                            <span class="similarity-score">89%</span>
                            <span class="similarity-label">Match</span>
                        </div>
                        <div class="precedent-info">
                            <h3>Illumina / Grail</h3>
                            <div class="precedent-meta">Sep 2020 ‚Ä¢ Strategic Acquisition</div>
                            <div class="precedent-tags">
                                <span class="tag match">Biotech</span>
                                <span class="tag match">Pending FDA</span>
                                <span class="tag">Regulatory Block</span>
                            </div>
                        </div>
                    </div>
                    <div class="precedent-metrics">
                        <div class="metric">
                            <div class="metric-value">$8B</div>
                            <div class="metric-label">Deal Value</div>
                        </div>
                        <div class="metric">
                            <div class="metric-value">N/A</div>
                            <div class="metric-label">EV/EBITDA</div>
                        </div>
                        <div class="metric">
                            <div class="metric-value">N/A</div>
                            <div class="metric-label">Premium</div>
                        </div>
                        <div class="metric">
                            <div class="metric-value">36 mo</div>
                            <div class="metric-label">Duration</div>
                        </div>
                    </div>
                    <div class="precedent-outcome">
                        <span class="outcome-status terminated">‚úó Divested</span>
                        <div class="outcome-detail">EU regulatory block</div>
                    </div>
                </div>

                <!-- Precedent 4 -->
                <div class="precedent-card">
                    <div class="precedent-main">
                        <div class="similarity-badge medium">
                            <span class="similarity-score">87%</span>
                            <span class="similarity-label">Match</span>
                        </div>
                        <div class="precedent-info">
                            <h3>Amgen / Horizon Therapeutics</h3>
                            <div class="precedent-meta">Dec 2022 ‚Ä¢ Strategic Acquisition</div>
                            <div class="precedent-tags">
                                <span class="tag match">Biotech</span>
                                <span class="tag match">Rare Disease</span>
                                <span class="tag">FTC Review</span>
                            </div>
                        </div>
                    </div>
                    <div class="precedent-metrics">
                        <div class="metric">
                            <div class="metric-value">$27.8B</div>
                            <div class="metric-label">Deal Value</div>
                        </div>
                        <div class="metric">
                            <div class="metric-value">19.8x</div>
                            <div class="metric-label">EV/EBITDA</div>
                        </div>
                        <div class="metric">
                            <div class="metric-value">48%</div>
                            <div class="metric-label">Premium</div>
                        </div>
                        <div class="metric">
                            <div class="metric-value">10 mo</div>
                            <div class="metric-label">Time to Close</div>
                        </div>
                    </div>
                    <div class="precedent-outcome">
                        <span class="outcome-status completed">‚úì Completed</span>
                        <div class="outcome-detail">FTC cleared with conditions</div>
                    </div>
                </div>
            </div>

            <!-- AI Insights -->
            <div class="insights-section">
                <div class="insights-header">
                    <div class="insights-icon">üß†</div>
                    <div>
                        <div class="insights-title">Precedent Intelligence</div>
                        <div class="insights-subtitle">AI analysis of 23 comparable transactions</div>
                    </div>
                </div>

                <div class="insights-grid">
                    <div class="insight-card">
                        <div class="insight-stat">73%</div>
                        <div class="insight-label">Consent Success Rate</div>
                        <div class="insight-detail">Of deals with "sole discretion" CoC clauses that approached licensor pre-LOI, 73% obtained consent.</div>
                    </div>
                    
                    <div class="insight-card">
                        <div class="insight-stat">12.8x</div>
                        <div class="insight-label">Median EV/EBITDA</div>
                        <div class="insight-detail">For comparable biotech acquisitions with pending FDA approvals. NovaPharma's implied 10.5x suggests upside.</div>
                    </div>
                    
                    <div class="insight-card">
                        <div class="insight-stat">38%</div>
                        <div class="insight-label">Used Earnouts</div>
                        <div class="insight-detail">Of deals with regulatory uncertainty used milestone-based earnouts. Average contingency was 35% of deal value.</div>
                    </div>
                </div>
            </div>
        </main>
    </div>
</body>
</html>
